Midgard Finance drug data

com.midgardfinance/drugsVersion 0.1.2

Obesity and incretin drug trials: weight loss by dose with its estimand, adverse events, catalysts

Status

Responds108 msNov 14, 2026, 14:06 UTCAnswered our handshake without sign-in.

Registry data may be out of date

We could not refresh it, so this page shows the last copy.

Last checked: Nov 14, 2026, 14:06 UTC
Latency: 108 ms
Remotes responding: 1 of 1
Sign-in: No sign-in
Hosting: EU hosting detected (detected, not a legal statement)
Registry data as of: Nov 14, 2026, 22:14 UTC

Data from the official MCP Registry, checked by run.zero. How we check

Connect

Streamable HTTP

https://mcp.midgardfinance.com/mcpResponds108 msNov 14, 2026, 14:06 UTC

No sign-in

Claude Code

claude mcp add --transport http drugs https://mcp.midgardfinance.com/mcp

Claude Desktop and claude.ai

1
2
3

Settings > Connectors > Add custom connector
Name: drugs
Remote MCP server URL: https://mcp.midgardfinance.com/mcp

Cursor

{
  "mcpServers": {
    "drugs": {
      "url": "https://mcp.midgardfinance.com/mcp"
    }
  }
}

VS Code

code --add-mcp '{"name":"drugs","type":"http","url":"https://mcp.midgardfinance.com/mcp"}'

Built your own server? run.zero hosts MCP servers on European infrastructure.

Host your own MCP server on run.zero

Tools

8 tools

Tools of Midgard Finance drug data
	Description		Read-only	Idempotent	Open world
`compare_efficacy`The extracted weight-loss table for the named drugs, joined to trial design, one row per arm and timepoint. Rows are NOT collapsed to one number per drug. The corpus holds several doses, timepoints and estimands per trial, and picking a single winner per drug would mean choosing between them here, silently and on the caller's behalf. The comparison is theirs to make; this returns the rows and the labels needed to make it correctly.	The extracted weight-loss table for the named drugs, joined to trial design, one row per arm and timepoint. Rows are NOT collapsed to one number per drug. The corpus holds several doses, timepoints and estimands per trial, and picking a single winner per drug would mean choosing between them here, silently and on the caller's behalf. The comparison is theirs to make; this returns the rows and the labels needed to make it correctly.	No	Yes	Not declared	No
`get_adverse_events`Extracted adverse-event rates for a named drug or trial, by arm, with the arithmetic that was checked. `drug` is a molecule or a brand (tirzepatide or Zepbound). `ae_type` narrows to a kind of event, every word of it found in the stored type: discontinuation_ae is the share who stopped the drug because of an adverse event (quit over side effects), and the others include discontinuation_ae_gi, nausea, vomiting, diarrhea, constipation, serious_ae, any_ae and death. `available_ae_types` lists the types the named drug or trial holds. `not_published` names the matching trials that hold no rows because their side-effect figures were never published, with what the sponsor did say (REDEFINE 4, the CagriSema and tirzepatide head-to-head). `verification` is carried through verbatim. It is the raw-count recomputation recorded when the row was extracted ("997/2481 active = 40.18%"), and it is what lets a caller see that the percentage was checked against the paper rather than copied from an abstract.	Extracted adverse-event rates for a named drug or trial, by arm, with the arithmetic that was checked. `drug` is a molecule or a brand (tirzepatide or Zepbound). `ae_type` narrows to a kind of event, every word of it found in the stored type: discontinuation_ae is the share who stopped the drug because of an adverse event (quit over side effects), and the others include discontinuation_ae_gi, nausea, vomiting, diarrhea, constipation, serious_ae, any_ae and death. `available_ae_types` lists the types the named drug or trial holds. `not_published` names the matching trials that hold no rows because their side-effect figures were never published, with what the sponsor did say (REDEFINE 4, the CagriSema and tirzepatide head-to-head). `verification` is carried through verbatim. It is the raw-count recomputation recorded when the row was extracted ("997/2481 active = 40.18%"), and it is what lets a caller see that the percentage was checked against the paper rather than copied from an abstract.	No	Yes	Not declared	No
`get_drug`Full record for one drug, with its efficacy figures estimand-tagged and its page URL. Matching goes slug, then exact name or brand, then substring, so "wegovy", "Wegovy HD" and "semaglutide-obesity" all land somewhere sensible without the caller knowing the slug scheme.	Full record for one drug, with its efficacy figures estimand-tagged and its page URL. Matching goes slug, then exact name or brand, then substring, so "wegovy", "Wegovy HD" and "semaglutide-obesity" all land somewhere sensible without the caller knowing the slug scheme.	No	Yes	Not declared	No
`get_trajectory`The digitised weight-loss curve for a drug: week-by-week points, plus per-dose series. Returned with `endpoint_pct` and its estimand alongside the curve, because the endpoint marker and the last plotted point are different quantities and the curve alone does not say which one a reader is looking at.	The digitised weight-loss curve for a drug: week-by-week points, plus per-dose series. Returned with `endpoint_pct` and its estimand alongside the curve, because the endpoint marker and the last plotted point are different quantities and the curve alone does not say which one a reader is looking at.	No	Yes	Not declared	No
`get_trial`One trial's design, by NCT number or by trial key (SURMOUNT-1, scale, redefine-1).	One trial's design, by NCT number or by trial key (SURMOUNT-1, scale, redefine-1).	No	Yes	Not declared	No
`list_catalysts`Upcoming and recent readouts, approvals and trial starts across sponsors, oldest first. For what comes next, pass from_date as today and pending_only=true, and kind="readout" for trial results; an event whose outcome is set has already happened. from_date and to_date take YYYY-MM-DD, YYYY-MM, YYYY-Qn or YYYY. An event is dated as precisely as its sponsor guided it (a day, a month, a quarter or a year), and it is kept when that period overlaps the window, so an event guided to 2026-Q4 is still listed from 2026-11-10. area: "obesity" or "diabetes". kind: "readout" (trial results, including cardiovascular outcomes trials), "regulatory" (submissions, decisions, coverage and launches), "trial_start" or "company" (earnings, conferences, investor days). pending_only: only events with no outcome recorded yet.	Upcoming and recent readouts, approvals and trial starts across sponsors, oldest first. For what comes next, pass from_date as today and pending_only=true, and kind="readout" for trial results; an event whose outcome is set has already happened. from_date and to_date take YYYY-MM-DD, YYYY-MM, YYYY-Qn or YYYY. An event is dated as precisely as its sponsor guided it (a day, a month, a quarter or a year), and it is kept when that period overlaps the window, so an event guided to 2026-Q4 is still listed from 2026-11-10. area: "obesity" or "diabetes". kind: "readout" (trial results, including cardiovascular outcomes trials), "regulatory" (submissions, decisions, coverage and launches), "trial_start" or "company" (earnings, conferences, investor days). pending_only: only events with no outcome recorded yet.	No	Yes	Not declared	No
`list_news`The latest news the site's hubs print, newest first, with date, headline, source and page. Use it for "what is new" and "latest announcement" questions. It holds the eight newest items of each hub: obesity, Novo Nordisk and Eli Lilly. `company` matches the hub (Novo Nordisk, Eli Lilly) or the drug's sponsor, `drug` a drug or brand in the item or its headline, `query` a word in the headline (MASH, approval). `kind` on a Novo hub item says what it is (clinical, regulatory, corporate, results, competitor: a rival's event that bears on Novo). An event older than a hub's eight newest is not here: say so rather than guess. A headline's efficacy figure is on the estimand the headline names, if any, and is not comparable with one on another.	The latest news the site's hubs print, newest first, with date, headline, source and page. Use it for "what is new" and "latest announcement" questions. It holds the eight newest items of each hub: obesity, Novo Nordisk and Eli Lilly. `company` matches the hub (Novo Nordisk, Eli Lilly) or the drug's sponsor, `drug` a drug or brand in the item or its headline, `query` a word in the headline (MASH, approval). `kind` on a Novo hub item says what it is (clinical, regulatory, corporate, results, competitor: a rival's event that bears on Novo). An event older than a hub's eight newest is not here: say so rather than guess. A headline's efficacy figure is on the estimand the headline names, if any, and is not comparable with one on another.	No	Yes	Not declared	No
`search_drugs`Search the drug boards by free text and by field. `query` also matches the other indications a molecule is pursuing, from the indications matrix (MASH, CKD, sleep apnea, heart failure, CV outcomes, type 2 diabetes, and their trial names), so "MASH" finds every cardiometabolic drug with a MASH programme and its status. `sponsor` also matches a partner the matrix names (survodutide is licensed from Zealand Pharma to Boehringer Ingelheim). Each result carries its `indications` row, or null for a drug the matrix does not cover (cancer and immunology drugs, and MASH-only drugs, are not in it).	Search the drug boards by free text and by field. `query` also matches the other indications a molecule is pursuing, from the indications matrix (MASH, CKD, sleep apnea, heart failure, CV outcomes, type 2 diabetes, and their trial names), so "MASH" finds every cardiometabolic drug with a MASH programme and its status. `sponsor` also matches a partner the matrix names (survodutide is licensed from Zealand Pharma to Boehringer Ingelheim). Each result carries its `indications` row, or null for a drug the matrix does not cover (cancer and immunology drugs, and MASH-only drugs, are not in it).	No	Yes	Not declared	No

Details

Registry status: Active
Published: Oct 30, 2026
Updated: Oct 30, 2026
Website: https://www.midgardfinance.com/obesity/⁠ (opens in a new tab)
Repository: Not given
Categories (suggested): Search and web Finance and paymentsSuggested categories are assigned automatically from the registry text and may be wrong. Verified operators can correct them.
GDPR: Not declared

Are you the operator? Claim this listing